follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeHealthHealthcare

      Healthcare

      Companies in the healthcare industry include medical physicians, hospitals, and alternative medicine practitioners. 

      The Healthcare industry covers both mental and physical well being and is focused on the maintenance or improvement of health. Companies that work in prevention, diagnosis, and treatment of disease, as well as illness, injury, and other physical and mental impairments, are found in the healthcare sector.

      Examples include Natera Inc., DarioHealth and Novavax.

      Diffusion Pharmaceuticals
      Biotechnology

      Diffusion Pharmaceuticals Discloses $12M Underwritten Public Offering, Stock Plunges Nearly 40%

      Jan 18 Caroline Harris
      Last week, Diffusion Pharmaceuticals (NASDAQ:DFFN), a clinical-stage biotechnology company based in Charlottesville, Virginia, soared nearly 40% on the market after CEO David Kalergis presented an overview of the company to the crowd at San Francisco’s ... [Read]
      NeuroMetrix Stock Jumps
      Healthcare

      NeuroMetrix Stock Jumps on Collaboration Deal with GlaxoSmithKline

      Jan 17 Samara Malkin
      NeuroMetrix, Inc. (NASDAQ:NURO), a company that manufactures and sells wearable neuro-stimulation therapeutic devices, has entered into a collaboration deal with GlaxoSmithKline (NYSE:GSK). GlaxoSmithKline is one of the world’s largest science-led global healthcare companies. The collaboration ... [Read]
      Concert Pharmaceuticals Seeing Red
      Biotechnology

      Concert Pharmaceuticals Seeing Red; Stock Down Nearly 30% After PTAG Rejects its Grant

      Jan 12 Caroline Harris
      Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) is seeing red. The market closes in twenty minutes, which doesn’t give the Lexington, Massachusetts-based company enough time to try and make a comeback. As of this writing, Concert Pharmaceuticals is ... [Read]
      Healthcare

      Community Health Systems Up Almost 20% After Largest Shareholder Buys More Shares

      Jan 11 Chelsea Roh
      Community Health Systems, Inc (NYSE:CYH) shares rose 19.65%, as of 11:38 AM PST, on Thursday. The company operates 127 hospitals, within 20 states around the United States. Investors of the stock can thank the company’s ... [Read]
      Biotechnology

      Diffusion Pharmaceuticals Presents TSC Candidate at Biotech Conference, Stock Climbs 35%

      Jan 9 Samara Malkin
      Diffusion Pharmaceuticals Inc. (NASDAQCM:DFFN) has experienced a stock increase of 35% today on the Nasdaq Capital Market. At the time of writing, the stock has moved $0.43, from the previous closing price of $1.21 to ... [Read]
      Aradigm Corporation
      Drug Manufacturers

      Aradigm Corporation Dropped More Than 30% Today, Here’s Why

      Jan 9 Caroline Harris
      Regardless of whether or not you are an Aradigm Corporation (NASDAQ:ARDM) shareholder, it is crucial that the entire marketplace becomes aware of the latest news surrounding the Hayward, California-based specialty pharmaceutical company. What’s Happened? Despite ... [Read]
      Biotechnology

      Should You Be Investing in Biotech Stocks? Pain Therapeutics Up 150% and GT Biopharma Up Nearly 15%

      Jan 9 Caroline Harris
      What a way to start off the week! If you’re an investor, and you’re looking to spice up your investment portfolio, why not invest in some biotech stocks? Considering the industry has been doing quite ... [Read]
      Biotechnology

      Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.

      Jan 8 Chelsea Roh
      Switzerland-based Axovant Sciences Ltd (NASDAQ:AXON) shares have plummeted over 50% today as it announces it has scrapped its program and experiments for curing a type of dementia. The drug was called intrepirdine and it has ... [Read]
      Ignyta Inc. Investigation
      Biotechnology

      Ignyta Inc. Investigation Continues

      Dec 29 Samara Malkin
      When Ignyta Inc. (NASDAQ:RXDX) was bought by Roche Holding Ltc (OTCQX:RHHBF), the December 22 news brought on a huge spike in Ignyta’s stock price, which went from $15.55 to $26.85 that day. But it also ... [Read]
      vTv Therapeutics
      Biotechnology

      Is vTv Therapeutics Making a Comeback? Stock up Almost 40% Despite Plunging on Dec. 25

      Dec 28 Caroline Harris
      The general consensus surrounding stocks and the market is that it can be an extremely volatile environment, and it seems that vTv Therapeutics, Inc. (NASDAQ:VTVT) is living up to that reputation, and it is important ... [Read]

      Posts pagination

      « 1 … 4 5 6 … 13 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767